FDA seeking more info on Avedro’s corneal cross-linking NDA
April 22nd 2014Avedro Inc. has received a complete response letter from the U.S. Food and Drug Administration (FDA) regarding its new drug application (NDA) for riboflavin ophthalmic solution/KXL System to treat keratoconus and corneal ectasia after refractive surgery.
CooperVision unveils Eye Care Prime Premier, collaborates with AOSA
April 22nd 2014CooperVision, Inc., through its subsidiary WebSystem3 LLC, recently unveiled Eye Care Prime Premier, which brings individualized, digital marketing consulting and execution services to eyecare practices across the United States.
Alcon announces new Clear Care packaging, bottle enhancements
April 22nd 2014Clear Care Cleaning and Disinfecting Solution, produced by Alcon, now has packaging enhancements that include a newly redesigned closure system and an updated bottle design. The new cartons are expected to hit shelves as early as April 2014.
Promoting practice growth by investing in optical
April 21st 2014I sometimes wonder why, in the rush to build the medical model, so many of my colleagues seemingly abandon the retail aspects of our profession. Many ODs seem to want to forget or diminish that our historical contribution to vision has been mainly centered around the correction, refractive, and binocular vision function and development.
Responding to a request for PD measurements
April 17th 2014Most dispensing optometric practices are fielding frequent requests from their patient base to provide pupillary distance (PD) measurements along with a copy of a prescription for eyeglasses. There are varied responses among doctors, the eyecare professionals (ECPs), and other staff members as to how to handle this request.
Moran Eye Center publishes retinopathy of prematurity research
April 15th 2014The University of Utah’s John A. Moran Eye Center has published a research paper originating from the center examining the role of erythropoietin (EPO) signaling in retinopathy of prematurity (ROP) in the American Journal of Pathology.
Irish researches find potential therapy for wet AMD
April 10th 2014Scientists at Trinity College Dublin have found that a component of the immune system suppresses the production of damaging blood vessels behind the retina, which could aid in the treatment of wet age-related macular degeneration, according to research recently published in Science Translational Medicine.